Precigen Inc (PGEN)
Healthcare
Biotechnology
6.50 $
-1.2%
vs. previous close
Closing price · As of: 4. Aug 2026
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.5% | -2.2% | -1.2% | +0.1% | -57.8% | -1.9% | -4.8% | +0.2% | +27.5% | +41.6% | -3.3% | – | |
| – | +5.3% | -1.9% | +14.1% | -23.9% | +4.9% | +39.0% | -6.6% | -38.8% | +167.9% | -50.7% | +39.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -90.4% | +13,961.5% | -67.3% | -75.7% | -428.3% | – | +4.4% | +188.5% | -87.1% | -441.5% | – | – | |
| – | +133.7% | +342.8% | +316.4% | -46.6% | -62.0% | +16.6% | -39.5% | +55.3% | -59.7% | +59.9% | -58.5% | – | |
| – | -55.2% | +26.3% | +80.9% | -37.8% | -62.2% | -1,256.3% | -90.1% | – | -322.9% | – | -47.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -467.3% | -72.8% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.2% | -90.8% | -100.0% | – | +61,682.7% | +144.0% | -100.9% | +160.1% | – | -100.6% | – | – | |
| – | – | – | – | -182.2% | – | -68.3% | -589.5% | – | -92.7% | +2,731.3% | -243.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.